Home
Conditions
Cell Transformation, Neoplastic

Clinical trial condition

Cell Transformation, Neoplastic

Explore clinical trials studying Cell Transformation, Neoplastic. Study availability and eligibility vary by location and protocol.

270 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Cell Transformation, Neoplastic trial results

Completed

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

NCT01427881

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +138 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

NCT00509691

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States

View Trial Details

Completed

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

NCT00248547

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +100 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

NCT00993694

Conditions: Amyloidosis, Anemia, Anemia, Aplastic, +101 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders

NCT00636909

Conditions: ALL, AML, Anemia, +40 more
Locations: Not specified

View Trial Details

Completed

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

NCT00755040

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +62 more
Locations: Stanford University Palo Alto, California, United States

Norwestern Memorial Hospital Chicago, Illinois, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

NCT00408681

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +221 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Aurora Presbyterian Hospital Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States

View all 326 locations

View Trial Details

Completed

Natural History Study of Patients With Chronic Myelogenous Leukemia

NCT00429910

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +16 more
Locations: Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00104975

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +58 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

View Trial Details

Cell Transformation, Neoplastic

Cell Transformation, Neoplastic trial results

Related conditions